Updated: May 15, 2023
This NABH-Covid-19 Resources page is designed to help NABH members access important and applicable resources as they navigate the Covid-19 pandemic. The first section includes PDF documents from NABH and other organizations, and the second section includes links to federal guidance and other applicable information from federal agencies and non-government organizations.
Thank you for the excellent care you and your teams continue to provide during this difficult time. Please write to us with concerns or questions at nabh@nabh.org.
Latest Resources
Archived Documents
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
1-29-21: CMS Issues Memo Clarifying Hospital Survey Expectations During Pandemic
1-18-21: HHS Updates PRF Reporting Requirements
12-18-20: Letter to Sec. Azar on Access to Covid-19 Vaccine for Mental Health and Addiction Treatment Providers and Consumers
12-11-20: HHS Covid-19 Guidance for Hospital Reporting and FAQs for Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting
12-3-20: NABH Letter to NGA on Covid-19 Vaccine Distribution
10-23-20: General and Targeted Distribution Post-Payment Notice of Reporting Requirements
10-17-20: CMS Infographic on Covid-19 Data Reporting
10-17-20: CMS Guidance on Covid-19 Data Reporting
8-13-20: HHS Provider Relief Fund Webinar Presentation
8-13-20: Provider Relief Fund Step-by-Step Provider Guide
8-13-20: Provider Relief Fund Stakeholder Toolkit
- 7-26-20: Updated CDC Guidelines on Infection Control in Psychiatric Hospitals
7-14-20: Covid-19 Guidance and FAQ for for Hospital Reporting
5-29-20: COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) Billing
5-26-20: Center for Connected Health Policy: Telehealth Policy in a Post-Covid-19 World
5-26-20: HHS Announces 45-Day Compliance Deadline Extension for Providers
5-11-20: CMS Provides Summary of Recent Actions
Provider Relief Fund (PFR)
1-1-22: HRSA Fact Sheet on Provider Relief Fund Reporting Period 2 (RP2)
9-15-21: HHS Announces the Availability of $25.5 Billion in COVID-19 Provider Funding
9-15-21: Provider Relief Fund Phase 3: Payment Calculation Methodology
9-15-21: Information on the application process and eligibility requirements
9-15-21: PRF Reporting Requirements
CARES Act
CDC
Staffing
- 7-14-21: NurseJournal article on Combatting Compassion Fatigue
- 9-3-20: HHS Updated Covid-19 Workforce Virtual Toolkit
- 7-14-20: 59 Mental Health Resources for Health Care Providers
- CMS Medicare Provider Enrollment Relief FAQs
- CMS 1135 Waiver Checklist Template CMS Guidance 1135
Addiction
SAMHSA:
- SAMHSA Covid-19 Resources and Information
- Social Distancing, Quarantine, and Isolation Guidance
- Considerations for Mental Health and SUD Treatment
- Considerations for Alcohol-Benzodiazephine Withdrawal
- OTP Guidance
- OTP Doorstep Delivery Guidance
- 42 CFR Part 2 Guidance
- Virtual Recovery Resources
- Disaster Planning Handbook
National Academy for State Health Policy
- 5-19-20: State Actions to Strengthen Workforce Capacity to Address OUD during COVID-19
- State Strategies for OUD Treatment During Covid-19 Pandemic
HHS Office for Civil Rights
American Society of Addiction Medicine
ASAM Covid-19 Resources (4-2-20)
Motivational Incentives Policy Group
Letter to Sec. Alex Azar on implementation of Motivational Incentives
Infection Control
- 7-26-20: Updated CDC Guidelines on Infection Control in Psychiatric Hospitals
- 4-9-20: CMS Updated Guidance on Infection Control for ICF/IID & PRTF
- 4-9-20: CMS Updated Guidance on Infection Control for Hospitals
- CMS Infection Control Guidance for Outpatient Settings
- The Joint Commission’s Covid-19 Infection Control Guidance
- National Institute of Environmental Health Sciences Resources
Personal Protective Equipment (PPE)
- 4-6-20: Federal Trade Commission Webpage About Covid-19 Consumer Protections
- CDC Strategies on Optimizing PPE Supply
- FDA Guidance on Emergency Use Authorization for PPE
- Guidance on Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (REVISED)
- Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respirators
- NIOSH-Approved Air Purifying Respirators for Use in Health Care Settings During Response to the COVID-19 Public Health Emergency
CMS
- 5-20-20: CMS Updated Guidance on Emergency Declaration Blanket Waivers for Health Care Providers
- 5-6-20: CMS Releases Updated FAQs
- CMS Announces Relief for Quality Reporting Programs
- CMS Guidance for Healthcare Providers
- CMS Virtual Toolkit
- CMS Guidance on section 1135 authority that allows waiver of certain Medicare, Medicaid, and Children’s Health Insurance Program (CHIP) requirements
EMTALA
Telehealth
- 8-13-20: Manatt Research on Telehealth Coverage After Public Health Emergency
- 5-7-20: Brookings Publishes Report on Removing Regulatory Barriers to Telehealth
- 5-5-20: AHRQ Releases Guidance for Obtaining Consent for Telehealth
- 4-23-23: CMS State Medicaid and CHIP Telehealth Toolkit
- 4-2-20: DEA and SAMSHA Release Guidance on Buprenorphine and Telemedicine
- 3-24-20: CMS Telehealth March 24 FAQs
- CMS 2020 Telehealth Services Booklet
- Telehealth Coverage Policies Summary from the Center for Connected Health Policy
- CMS Guidance and FAQs on Telehealth in Medicare
- CMS Guidance on Telehealth in Medicaid
- HHS Office of Inspector General (OIG) Policy Statement and Fact Sheet on Telehealth Cost-Sharing
- HHS Office for Civil Rights Guidance on Waiver of HIPAA Sanctions and Penalties Related to Telehealth
- Drug Enforcement Administration Guidance on Telemedicine and Medication-Assisted Treatment
State Policies
- State Strategies for OUD Treatment During Covid-19 Pandemic
- National Governors Association Covid-19 Updates
- Kaiser Family Foundation Medicaid Emergency Authority Tracker
Other
- 4-17-20: NIMH Shareable Resources on Coping with Covid-19
- 4-15-20: Manatt’s Overview of FEMA Public Assistance Program Funding for Covid-19
- 4-6-20: OIG Statement on Administrative Enforcement Authorities due to Covid-19 Emergency
- Updated 4-2-20: U.S. Labor Department’s FAQs on the Families First Coronavirus Response Act
- HHS’ Office of Inspector General released a COVID-19 Fraud Alert with general information
- HHS Office of Inspector General’s Covid-19 Portal
- The Joint Commission’s Webinar on Preparing Behavioral Health Organizations for Covid-19
- HRSA Covid-19 Funding, Resources, and Oversight FAQs
- HRSA Technical Assistance for Award Recipients
NABH Covid-19 Task Force
NABH’s Covid-19 Task Force works with the NABH team in Washington to identify the most challenging issues facing U.S. behavioral healthcare providers during the Covid-19 pandemic. The task force will also develop recommendations that NABH will share with relevant federal agencies, congressional offices, and the general public.
- Pat Connell, R.N., M.B.A., F.A.C.H.E., C.B.H.E., C.H.C., Boys Town Behavioral Health Division
- Michael Genovese, M.D., J.D., Acadia Healthcare, Inc.
- Frank A. Ghinassi, Ph.D., A.B.P.P., Rutgers University Behavioral Health Care/RWJBarnabas Health
- Karen Johnson, M.S.W., Universal Health Services, Inc.
- Gail Ryder, M.S., BayCare Behavioral Health
- Mark Schneider, Vizion Health, LLC
- Harsh K. Trivedi, M.D., M.B.A., Sheppard Pratt
- Rochelle Archuleta, Co-Staff Liaison, National Association for Behavioral Healthcare
- Shawn Coughlin, Co-Staff Liaison, National Association for Behavioral Healthcare